Published in Int J Mol Sci on January 06, 2014
c-Jun N-terminal Kinase (JNK) Signaling as a Therapeutic Target for Alzheimer's Disease. Front Pharmacol (2016) 0.90
Mutation and Transcriptional Profiling of Formalin-Fixed Paraffin Embedded Specimens as Companion Methods to Immunohistochemistry for Determining Therapeutic Targets in Oropharyngeal Squamous Cell Carcinoma (OPSCC): A Pilot of Proof of Principle. Head Neck Pathol (2014) 0.78
Interleukin-37 expression and its potential role in oral leukoplakia and oral squamous cell carcinoma. Sci Rep (2016) 0.76
FOXC2 and CLIP4 : a potential biomarker for synchronous metastasis of ≤7-cm clear cell renal cell carcinomas. Oncotarget (2016) 0.75
Expression of cell adhesion molecules in laryngeal carcinoma - preliminary analysis. Contemp Oncol (Pozn) (2014) 0.75
Cytotoxic Effect of Coscinium fenestratum on Human Head and Neck Cancer Cell Line (HN31). Evid Based Complement Alternat Med (2015) 0.75
Prognostic value from integrative analysis of transcription factors c-Jun and Fra-1 in oral squamous cell carcinoma: a multicenter cohort study. Sci Rep (2017) 0.75
Interleukin-6 regulates iron-related proteins through c-Jun N-terminal kinase activation in BV2 microglial cell lines. PLoS One (2017) 0.75
Inflammation and cancer. Nature (2002) 53.78
Cancer metastasis: building a framework. Cell (2006) 19.67
Integrins in cancer: biological implications and therapeutic opportunities. Nat Rev Cancer (2010) 11.16
Signal-induced site-specific phosphorylation targets I kappa B alpha to the ubiquitin-proteasome pathway. Genes Dev (1995) 7.36
The origin and function of tumor-associated macrophages. Immunol Today (1992) 5.12
Interleukin-6 biology is coordinated by membrane-bound and soluble receptors: role in inflammation and cancer. J Leukoc Biol (2006) 3.45
ICAM-1 signaling in endothelial cells. Pharmacol Rep (2009) 3.06
Intercellular adhesion molecule-1. J Mol Med (Berl) (1996) 2.94
Interleukin-6 (IL-6) functions as an in vitro autocrine growth factor in renal cell carcinomas. FEBS Lett (1989) 2.43
Interleukin-6 as a paracrine and autocrine growth factor in human prostatic carcinoma cells in vitro. Cancer Res (1997) 1.95
Cell adhesion molecules: role and clinical significance in cancer. Cancer Invest (2009) 1.80
Role of ICAM1 in invasion of human breast cancer cells. Carcinogenesis (2005) 1.59
The Syk kinase as a therapeutic target in leukemia and lymphoma. Expert Opin Investig Drugs (2011) 1.58
Growth inhibition of human breast carcinoma and leukemia/lymphoma cell lines by recombinant interferon-beta 2. Proc Natl Acad Sci U S A (1988) 1.50
Disparity in pathologic and clinical lymph node staging in oral tongue carcinoma. Implication for therapeutic decision making. Cancer (2003) 1.41
Interleukin-6 undergoes transition from paracrine growth inhibitor to autocrine stimulator during human melanoma progression. J Cell Biol (1993) 1.37
IL-6 trans-signaling in formation and progression of malignant ascites in ovarian cancer. Cancer Res (2010) 1.31
Interleukin-6 functions as an autocrine growth factor in human bladder carcinoma cell lines in vitro. Int J Cancer (1997) 1.23
Molecular identification of a novel fibrinogen binding site on the first domain of ICAM-1 regulating leukocyte-endothelium bridging. J Biol Chem (1997) 1.23
Prostaglandin E2/EP1 signaling pathway enhances intercellular adhesion molecule 1 (ICAM-1) expression and cell motility in oral cancer cells. J Biol Chem (2010) 1.22
The CCL5/CCR5 axis promotes interleukin-6 production in human synovial fibroblasts. Arthritis Rheum (2010) 1.21
RANKL increases migration of human lung cancer cells through intercellular adhesion molecule-1 up-regulation. J Cell Biochem (2011) 1.06
Endothelin-1 promotes MMP-13 production and migration in human chondrosarcoma cells through FAK/PI3K/Akt/mTOR pathways. J Cell Physiol (2012) 1.06
Cell adhesion molecules, the extracellular matrix and oral squamous carcinoma. Int J Oral Maxillofac Surg (2007) 1.06
Thrombin induces epidermal growth factor receptor transactivation and CCL2 expression in human osteoblasts. Arthritis Rheum (2012) 1.05
Cell adhesion molecules and oral cancer. Crit Rev Oral Biol Med (2001) 1.03
Inhibition of ICAM-1 gene expression, monocyte adhesion and cancer cell invasion by targeting IKK complex: molecular and functional study of novel alpha-methylene-gamma-butyrolactone derivatives. Carcinogenesis (2004) 1.01
Interleukin-6 (IL-6) functions as an autocrine growth factor in cervical carcinomas in vitro. Gynecol Oncol (1993) 1.00
Apoptosis signal-regulating kinase 1 is involved in WISP-1-promoted cell motility in human oral squamous cell carcinoma cells. PLoS One (2013) 0.99
IL-6 promotes ICAM-1 expression and cell motility in human osteosarcoma. Cancer Lett (2012) 0.98
Inhibitors targeting the LFA-1/ICAM-1 cell-adhesion interaction: design and mechanism of action. Curr Pharm Des (2008) 0.98
IL-6 increases MMP-13 expression and motility in human chondrosarcoma cells. J Biol Chem (2011) 0.95
HGF and c-Met interaction promotes migration in human chondrosarcoma cells. PLoS One (2013) 0.92
Combined effects of icam-1 single-nucleotide polymorphisms and environmental carcinogens on oral cancer susceptibility and clinicopathologic development. PLoS One (2013) 0.92
CCN4 induces vascular cell adhesion molecule-1 expression in human synovial fibroblasts and promotes monocyte adhesion. Biochim Biophys Acta (2013) 0.88
Autocrine effect of androgen on proliferation of an androgen responsive prostatic carcinoma cell line, LNCAP: role of interleukin-6. Endocrinology (1997) 0.87
CCN6 enhances ICAM-1 expression and cell motility in human chondrosarcoma cells. J Cell Physiol (2012) 0.87